New pill aims to control iron overload in genetic disorder
Disease control
Not yet recruiting
This early-stage trial tests an oral drug called BBI-001 for hereditary hemochromatosis, a condition causing too much iron in the body. The study has two parts: one with healthy volunteers to check safety, and another with patients to see how the drug affects iron levels. Partici…
Phase: PHASE1, PHASE2 • Sponsor: Bond Biosciences • Aim: Disease control
Last updated May 01, 2026 15:57 UTC